A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19
Clinical trial NCT04940182 · COMPLETED
Trial details
- NCT number
- NCT04940182
- Sponsor
- RSV Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-26
- Primary completion
- 2022-08-26
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.